CT-2584
CAS No. 166981-13-1
CT-2584 ( —— )
产品货号. M34217 CAS No. 166981-13-1
CT-2584 是一种化疗化合物,可降低几种肿瘤细胞类型中NKEF-B的表达,并通过诱导线粒体中 ROS 的产生来杀死肿瘤细胞,常用于癌症研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥4302 | 有现货 |
|
| 5MG | ¥6379 | 有现货 |
|
| 10MG | ¥9044 | 有现货 |
|
| 25MG | ¥13059 | 有现货 |
|
| 50MG | ¥17048 | 有现货 |
|
| 100MG | ¥21420 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称CT-2584
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述CT-2584 是一种化疗化合物,可降低几种肿瘤细胞类型中NKEF-B的表达,并通过诱导线粒体中 ROS 的产生来杀死肿瘤细胞,常用于癌症研究。
-
产品描述CT-2584 is a chemotherapeutic compound that reduces the expression of NKEF-B in several tumor cell types and kills tumor cells by inducing the production of ROS in mitochondria, commonly used in cancer research.
-
体外实验Cell Viability Assay Cell Line:ECV304 and its derived cell lines Concentration:0-7 μM Incubation Time:3 days Result:Inhibited ECV304 and B/1 cells with the LC50 value of 4.5 μ M and 6.5 μ M,respectively. After 7 μM treatment, the shape of ECV304 or ECV304/pCE2 cells became round and detached from the plate, while B/1 cells could clearly observe living cells that retained the spindle shape.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Reactive Oxygen Species
-
研究领域——
-
适应症——
化学信息
-
CAS Number166981-13-1
-
分子量533.79
-
分子式C30H55N5O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C1C2=C(N=CN2C)N(C(=O)N1CCCCCCCCCC(O)CNCCCCCCCCCCCC)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. H Shau, et al. Endogenous natural killer enhancing factor-B increases cellular resistance to oxidative stresses. Free Radic Biol Med. 1997;22(3):497-507. ?
产品手册
关联产品
-
Avatrombopag
Avatrombopag 是一种新型口服血小板生成素 (TPO) 受体激动剂,可激活 TPO 受体并增加巨核细胞增殖/分化和血小板生成。
-
HIV Integrase Protei...
His-Cys-Lys-Phe-Trp-Trp is an inhibitor for the human immunodeficiency virus (HIV) integrase with an IC50 of 2 μM.
-
Thalidomide-5-methyl
Thalidomide-5-methyl 是基于沙利度胺的 cereblon (CRBN) 配体,用于招募 CRBN 蛋白。
021-51111890
购物车()
sales@molnova.cn

